Vanguard Group »

Regulus Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 740k 2.88
2023-12-31 $367k 286k 1.28
2023-09-30 $391k 285k 1.37
2023-06-30 $416k 283k 1.47
2023-03-31 $240k 283k 0.85
2022-12-31 $387k 283k 1.37
2022-06-30 $772k 373k 2.07